Kewaunee Scientific Corporation KEQU

Q1 FY2027 · ended Jul 31, 2026 · Revenue $66.32M, -6.7% YoY · Filed Sep 11, 2026

Kewaunee Scientific Corporation (KEQU) files with the SEC under industry code 3821, Laboratory Apparatus & Furniture. In Q1 of fiscal 2027, the quarter ended Jul 31, 2026, it reported revenue of $66.3 million and net income of $1.7 million. Free cash flow was $1.2 million. As of Jul 31, 2026 it held $8.2 million in cash and investments and $28.8 million in total debt.

Revenue
$66.32M
-6.7% vs year-ago quarter
Net income
$1.71M
-44.8% vs year-ago quarter
Operating cash flow
$1.98M
-65.9% vs year-ago quarter
Free cash flow
$1.20M
-76.0% vs year-ago quarter
EPS
$0.58
-44.2% vs year-ago quarter
Dividend per share
None
Shares outstanding
2.90M
+1.0% vs year-ago quarter
Net cash
$-20.54M
Q1 FY2027
Operating margin
5.4%
TTM

Company profile

Industry
Laboratory Apparatus & Furniture (SIC 3821)
Listed as
KEQU (Nasdaq)
Fiscal year ends
April 30
Incorporated in
DE
Headquarters
Statesville, NC
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
55529

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q1 FY2027
Jul 31, 2026
Q4 FY2026
Apr 30, 2026
Q3 FY2026
Jan 31, 2026
Q2 FY2026
Oct 31, 2025
Q1 FY2026
Jul 31, 2025
Revenue
$66.3M
$71.4M
$69.4M
$70.1M
$71.1M
Operating income
$3.2M
$5.2M
$2.6M
$4.1M
$4.8M
Net income
$1.7M
$3.4M
$692,000
$2.4M
$3.1M
Diluted EPS
$0.58
$1.13
$0.23
$0.82
$1.04
Operating cash flow
$2.0M
$5.5M
$11.6M
-$4.3M
$5.8M
Free cash flow
$1.2M
$4.5M
$11.0M
-$5.8M
$5.0M
Total assets
$175.8M
$178.3M
$176.0M
$189.1M
$193.5M
Total liabilities
$98.6M
$101.5M
$103.4M
$117.4M
$124.6M
Stockholders' equity
$75.0M
$74.7M
$70.7M
$69.9M
$67.1M
Cash and investments
$8.2M
$9.9M
$8.2M
$12.6M
$19.5M
Total debt
$28.8M
$30.6M
$31.4M
$46.3M
$48.8M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Nov 2, 2026 Nov 2, 2026
10-Q Quarterly report Sep 11, 2026 Jul 31, 2026
8-K Current report
Results of operations
Sep 9, 2026 Sep 9, 2026
8-K Current report
Shareholder vote results
Aug 27, 2026 Aug 26, 2026
8-K Current report
Regulation FD disclosure
Aug 26, 2026 Aug 26, 2026
8-K Current report
Other events
Aug 25, 2026 Aug 25, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.